Rho activation in excitatory agonist-stimulated vascular smooth muscle

Area of Science:

• Vascular smooth muscle physiology
• Molecular signaling pathways
• GTPase biology

Background:

• Small GTPase Rho and Rho kinase are crucial for agonist-stimulated Ca(2+) sensitization in smooth muscle.
• These pathways regulate 20-kDa myosin light chain (MLC(20)) phosphorylation and contraction.

Purpose of the Study:

• To investigate the role of excitatory receptor agonists in activating RhoA in rabbit aortic smooth muscle.
• To determine the agonist-specific nature of RhoA activation and its relation to MLC(20) phosphorylation.

Main Methods:

• Utilized a pull-down assay with Rhotekin to measure active GTP-bound RhoA (GTP-RhoA).
• Administered various agonists including U-46619, norepinephrine, serotonin, histamine, endothelin-1, ANG II, and phorbol 12,13-dibutyrate.
• Employed the tyrosine kinase inhibitor genistein to assess signaling pathways.

Main Results:

• Excitatory agonists, particularly U-46619, induce sustained increases in GTP-RhoA in a dose-dependent manner.
• RhoA activation is agonist-specific, with U-46619, norepinephrine, serotonin, histamine, and ET-1 showing varying effects.
• ANG II and phorbol 12,13-dibutyrate did not increase GTP-RhoA levels.
• Genistein inhibited most agonist-induced RhoA activation, except for ET-1.

Conclusions:

• Excitatory agonists trigger RhoA activation in vascular smooth muscle in an agonist-specific manner.
• This RhoA activation is linked to the stimulation of MLC(20) phosphorylation and Ca(2+) sensitization.
• Findings highlight the differential signaling of various agonists through the RhoA pathway.